India’s Granules makes $22M play for Senn Chemicals to enter peptides CDMO business
24th February 2025 Uncategorised 0Granules shelled out a reported 20 million Swiss francs ($22.3 million) to acquire Swiss CDMO Senn Chemicals. The move positions the Hyderabad, India-based drug manufacturer to enter the booming peptides production business being driven by innovative weight-loss drugs.
More: India’s Granules makes M play for Senn Chemicals to enter peptides CDMO business
Source: fierce